Plain-English translation of NCT06813443 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This is a research study that brings together medical records, heart imaging tests, and tissue samples from patients with heart muscle disease across three major Italian hospitals. The researchers are looking for patterns—especially in tiny molecules called microRNAs—that could help doctors predict which patients with severely weakened hearts are the best candidates for a heart transplant. No new medications or experimental treatments are being tested; instead, the study uses standard heart tests that patients would normally receive.
Heart muscle disease can vary greatly from person to person, and doctors currently don't have reliable tools to predict who will benefit most from a heart transplant. This study aims to create a detailed registry and identify molecular markers that could help doctors make better, more personalized decisions about who truly needs a transplant and when.
You likely qualify if…
You likely don't qualify if…
If you enroll, you will share your existing medical records and information from your heart tests (such as echocardiograms and heart imaging scans) that you would normally have done as part of your regular care. If tissue samples are needed, they may be collected during procedures you are already undergoing for your heart condition. The study will follow your health over time, using your medical information to look for patterns that help predict transplant outcomes. There are no special study visits or experimental treatments—everything is part of standard care.
AI-generated summary from trial data · Jun 7, 2026 · Not medical advice
Italy